Navigation Links
Pharmalink AB Raises SEK 35 Million Through Share Issue
Date:1/4/2012

STOCKHOLM, January 4, 2012 /PRNewswire/ --

Pharmalink AB, today announces it has raised SEK 35 million through a rights issue of new shares to the Company's existing shareholders, including Industrifonden.

The new funds will be used to further advance Nefecon® and Busulipo™, Pharmalink's two lead product candidates. Nefecon is the first pharmaceutical product especially developed for patients with IgA nephropathy, the most common form of primary glomerulonephritis and a cause of end-stage renal disease requiring treatment with dialysis or transplantation. Nefecon has shown positive results in an open-labeled Phase II trial evaluating safety and efficacy and Pharmalink is currently focusing on preparing pivotal clinical trials.

Busulipo is being developed to provide a best-in-class conditioning agent for use priorto hematopoietic stem cell transplantation (HSCT), also often known as bone marrow transplantation. Busulipo has successfully undergone Phase II clinical trials and extensive data on efficacy, safety and pharmacokinetics compare positively with historical controls. Pharmalink is currently preparing for late stage clinical trials and for the registration and introduction of Busulipo into key global markets.

Pharmalink's Managing Director Johan Häggblad said, "Pharmalink's ability to raise capital in the current difficult economic climate reflects the potential of our product pipeline and the confidence our shareholders have in our Company and strategy. Our two main product candidates have shown very promising results and this new funding will support their further progress towards becoming new medicines for important indications."

Lennart Hansson, Investment Director at Industrifonden and member of the Pharmalink Board said: "As part of Industrifonden's investment strategy, we are seeking to direct more significant capital to work in those companies we believe will deliver major successes. Pharmalink is ve
'/>"/>

SOURCE Pharmalink
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pharmalink AB Receives US Orphan Drug Designation for Nefecon(R) (PL-56)
2. Grifols Agrees to Acquire Intellectual Property for Treatment of Post-Polio Syndrome From Pharmalink AB
3. Pharmalink AB Receives Patent for Nefecon(R) Principle
4. MacuCLEAR, Inc. Raises More Than $1M in Financing and Enters into Strategic Pacific Rim Partnership
5. Cohera Medical Raises Over $25 Million in Series C Round
6. ImmusanT Raises $20 Million in Series A Financing to Advance Immunotherapeutic and Diagnostic for Celiac Disease
7. arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B Round
8. Vista Partners Updates Coverage on Cellmid Limited; Raises Target Price to AUD $0.12
9. Bayer Virtual Walk for Hemophilia Raises Awareness and Funds for People With Bleeding Disorders
10. NxStage Reports Record Third Quarter 2011 Financial Results and Raises Revenue Guidance For 2011
11. FRC Praises House Committee for Holding Hearing on Conscience-Violating Obamacare Contraceptive Mandate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 31, 2015 /CNW/ - T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" or ... quality medical marijuana products and a licensed producer ("LP") ... Regulations ( Canada ) ("MMPR"), is pleased ... Corporation of the District of Saanich ... premises which now allows for commercial distribution of medical ...
(Date:3/31/2015)... 31, 2015 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ... Hydrochloride 150mg, 225mg and 300mg oral tablets, indicated for ... US market for Propafenone Hydrochloride 150mg, 225mg and 300mg ... Arthur S. Przybyl , President and ... the launch of our fourth product from the portfolio ...
(Date:3/31/2015)... DUBLIN , Mar. 27, 2015 Research ... announced the addition of the "European Laboratory ... Information System), by Type (Clinical Pathology Laboratory Information ... to 2019" report to their offering. ... estimated to grow at a CAGR of 7.6% ...
Breaking Medicine Technology:T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 2T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 3ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 2ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 3European Laboratory Information System Market Report 2015: Germany holds a larger share of the laboratory information systems market 2European Laboratory Information System Market Report 2015: Germany holds a larger share of the laboratory information systems market 3
(Date:3/31/2015)... Dr. François Blaudeau, the founder of Southern ... power morcellator lawsuit filed on behalf of ... metastatic leiomyosarcoma, a rare and aggressive form of uterine ... by her husband and is currently pending in the ... the power morcellator used during her March 2012 hysterectomy ...
(Date:3/31/2015)... 2015 RE/MAX agents across North America ... Miracle Network Hospitals® – most of it by making ... Home and Miracle Property programs, offices and agents across ... support to their local children’s hospitals, ensuring kids in ... partnering with Children’s Miracle Network Hospitals in 1992, RE/MAX ...
(Date:3/31/2015)... Blue Cross Blue Shield of New Jersey (Horizon BCBSNJ) ... fraud resulted in $45.4 million in savings -- identified ... -- in 2014. The $45.4 million represents the highest/recovery ... Special Investigations Unit (SIU) in 1983. Since 2005, ... , “Our SIU has progressively enhanced Horizon’s analytics ...
(Date:3/31/2015)... 31, 2015 The Denver Regional Council ... are planning an array of public activities which include ... Tour and a Unity Parade and Rally at Denver ... Day” – a national day of advocacy on April ... transportation funding. , The effort is being led by ...
(Date:3/31/2015)... Altima Technologies, Inc., the maker of ... and diagramming data center assets and audio-video devices, ... / Device Model, Dell N3000 Series, Dell N4000 ... PowerEdge r630, Cisco Catalyst 3850 Series, HP 2530 ... VMAX 200K, VMAX 400K , “With NetZoom Visio ...
Breaking Medicine News(10 mins):Health News:Power Morcellator Lawsuit Filed by Southern Med Law Alleges Wife’s Death Resulted from Cancer Spread via Uterine Morcellation 2Health News:Power Morcellator Lawsuit Filed by Southern Med Law Alleges Wife’s Death Resulted from Cancer Spread via Uterine Morcellation 3Health News:RE/MAX Agents Raise $8.75 Million for Children's Hospitals in 2014 2Health News:RE/MAX Agents Raise $8.75 Million for Children's Hospitals in 2014 3Health News:Horizon Blue Cross Blue Shield of New Jersey Saves Members, Health System a Record $45.4 Million through Anti-fraud Efforts 2Health News:DRCOG & RTD Invite The Public To Stand Up For Transportation Funding 2Health News:DRCOG & RTD Invite The Public To Stand Up For Transportation Funding 3Health News:Altima Adds More Hardware Devices to its NetZoom™ Visio® Stencils Device Library 2
... Fiscal 2009 --, -- Announces Preliminary Revenue and EPS for ... Second Quarter Results to be Released on November 10, 2008 ... (Nasdaq: CHDX ), a leading independent American provider of ... today,increased its revenue outlook for the second half of the ...
... JZZ Technologies, Inc. (Pink,Sheets: JZZI) announced today ... the period ended September 30, 2008 on or ... to date. "We have made,significant strides in product ... been cultivating over the last twelve,months," said Aaron ...
... step to manage your health in 2009 , ... London, Hertfordshire (PRWEB) ... health in 2009, is a ground-breaking ill-health prevention strategy and service by ... can do to achieve optimal health, live blood tests or Nutrition Microscopy ...
... proves to be a great help for children who are suffering ... ... November 3, 2008 -- Viagrabulk.com is a leading online drug store ... (Pulmonary Arterial Hypertension). Inhaled Nitric Oxide (INO) treatment is considered as ...
... 2008) Influenza vaccination rates for adolescents who suffer from ... according to a recent study. , The ... Pediatrics, was based at the Department of Ambulatory ... Pilgrim Health Care. , "Influenza vaccination has been recommended ...
... (IDF) announced today that Ms Ann Keeling has ... The International Diabetes Federation, headquartered in Brussels,Belgium, is ... It is the global advocate for the more ... healthcare providers., Ms Keeling takes the helm ...
Cached Medicine News:Health News:Chindex International, Inc. Announces Preliminary Second Quarter Results and Improved Revenue Outlook for Fiscal 2009 2Health News:Chindex International, Inc. Announces Preliminary Second Quarter Results and Improved Revenue Outlook for Fiscal 2009 3Health News:Chindex International, Inc. Announces Preliminary Second Quarter Results and Improved Revenue Outlook for Fiscal 2009 4Health News:Health and Nutrition Diagnostic Tool To Manage Your Health In 2009 2Health News:Health and Nutrition Diagnostic Tool To Manage Your Health In 2009 3Health News:Health and Nutrition Diagnostic Tool To Manage Your Health In 2009 4Health News:Viagra Bulk Effectively Cures Children with PAH (Pulmonary Arterial Hypertension) 2Health News:Flu vaccination rates lag for at-risk adolescents 2Health News:New Chief Executive Officer Joins International Diabetes Federation 2
... Used for vascular access. ... facilitates single wall puncture with ... sideport is visualized while maintaining ... Sideport exits the hub of ...
Used for arterial and venous punctures. The tapered hub design of the catheter facilitates wire guide introduction. Supplied sterile in peel-open packages. Intended for one-time use....
Used for placement of .035 inch (0.89 mm) or .038 inch (0.97 mm) diameter wire guides into the vascular system when a small 24 gage needle stick is desired....
Used for percutaneous introduction of balloon, electrode and closed or non-tapered end catheters for vascular and non-vascular use....
Medicine Products: